Cellectis S.A. American Depositary Shares (CLLS) News

Latest headlines that mention CLLS, newest first · each headline opens the original publisher

CLLS quote

Last price: $1.25
Day change: -6.72%
Next earnings: 2026-11-06

Quote & chart Expected move Insider trading IV rank history

CLLS headlines

last 30 days

Yahoo Finance 21d ago

Cellectis (CLLS) Exits Two CAR-T Programs. Can Gene Editing Justify the Clinical Reset?

General T2CLLS

Seeking Alpha News 22d ago

Cellectis: An 'All Or Nothing' Pivot To In-Vivo Gene Editing Is Worth Monitoring

General T2CLLS

Investing.com 22d ago

Barclays cuts Cellectis stock rating on gene editing concerns

General T3BCS CLLS

Seeking Alpha 23d ago

Cellectis falls as Citizens downgrades on pivot to genetic medicines

General T2CLLS

Seeking Alpha News 24d ago

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

General T2CLLS

Seeking Alpha 27d ago

Cellectis GAAP EPS of -$0.39, revenue of $14.45M

Earnings T2CLLS

Also mentioned with CLLS

30d

BCS1

Headlines that tag both tickers

CLLS news alerts

Get an alert by email or push when a new headline mentions CLLS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.